PACS Group, Inc. PACS 深 沪
已收盘 02-06 16:00:00 美东时间
38.68
+1.810
+4.91%
华盛通- 最 高38.81
- 今 开36.96
- 成交量 88.61万股
- 最 低 36.872
- 昨 收 36.87
- 总市值 60.58亿
- 52周最高 43.08
- 市盈率 静 107.65
- 换手率 0.57%
- 52周最低 7.50
- 委 比 0.00%
- 总股本 1.57亿
- 历史最高 43.92
- 量 比 0.91
- 振 幅 5.26%
- 历史最低 7.50
- 每 手 1
- 风险率 9.86%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多PACS Group Acquires Three Post-Acute Operations And the Real Estate of Four Facilities
PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") today announced that independently operated subsidiaries of the Company have acquired the operations of three post-acute care facilities, two located in Alaska and
01-21 06:47
PACS Group stockholders endorse directors, auditor and pay
The latest announcement is out from PACS Group Inc ( ($PACS) ). On December 19,...
2025-12-24 05:46
美股大行评级 | 潜在涨幅101%！12家机构集体上调美光目标价；Insmed、RPM、Vital Farms等遭多家大行下调评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从22美元升至22.5美元；HC Wainwright & Co.：维持Climb Bio"买入"评级，目标价从9美元升至11美元
2025-12-19 10:15
美股大行评级 | 德银首予Coinbase"买入"评级，目标价340美元；AERO获多家机构首予超配评级；大摩维持苹果"超配"评级，目标价升至315美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从9美元升至10美元；摩根大通：上调Recursion Pharmaceuticals评级至"超配"，目标价从10美元升至11美元
2025-12-18 10:54
JP Morgan Reinstates Overweight on PACS Group, Announces $44 Price Target
JP Morgan analyst Benjamin Rossi reinstates PACS Group (NYSE:PACS) with a Overweight and announces $44 price target.
2025-12-17 21:48
美股周涨跌榜 | 社交电商平台WeShop上市一周涨超275%；精密科学周涨超50%，获雅培230亿美元收购
社交电商平台WeShop上市一周涨超275%；精密科学周涨超50%，获雅培230亿美元收购；SEMrush周涨近67%，获Adobe收购>>
2025-11-22 10:30
美股大行评级 | 最高352美元！14家机构连夜上调英伟达目标价；劳氏、塔吉特、Wix.com等遭多家机构下调目标价
今日重点评级关注：Ascendiant Capital：维持Aclarion"买入"评级，目标价从22美元升至23美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从24美元升至26美元
2025-11-21 15:50
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) stock increased by 18.6% to $2.1...
2025-11-21 05:06
RBC Capital Maintains Outperform on PACS Group, Raises Price Target to $33
RBC Capital analyst Ben Hendrix maintains PACS Group (NYSE:PACS) with a Outperform and raises the price target from $32 to $33.
2025-11-20 23:11
What Sparked PACS Group Stock Jumped Over 45% In After-Hours Trading?
PACS Group shares surged in after-hours trading following strong third -quarter results and the completion of financial restatements.
2025-11-20 12:35
